Chemclin Diagnostics Co., Ltd. (SHA:688468)
China
· Delayed Price · Currency is CNY 7.20
-0.08 (-1.10%)
May 30, 2025, 3:00 PM CST
Chemclin Diagnostics Revenue
Chemclin Diagnostics had revenue of 81.30M CNY in the quarter ending March 31, 2025, a decrease of -27.01%. This brings the company's revenue in the last twelve months to 406.20M, down -10.88% year-over-year. In the year 2024, Chemclin Diagnostics had annual revenue of 436.29M, down -2.03%.
Revenue (ttm)
406.20M
Revenue Growth
-10.88%
P/S Ratio
6.99
Revenue / Employee
645.79K
Employees
629
Market Cap
2.84B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |